Analysis of structural requirements for Ah receptor antagonist activity: Ellipticines, flavones, and related compounds

Biochemical Pharmacology

Volumn 52, Issue 11, 1996, Pages 1787-1803

  Gasiewicz, Thomas A ^a   Kende, Andrew S ^a   Rucci, George ^a   Whitney, Brenda ^a   Willey, J Jeff ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Ah receptor binding; antagonism; ellipticines; flavones

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AH RECEPTOR AGONIST; AH RECEPTOR ANTAGONIST; ALPHA NAPHTHOFLAVONE DERIVATIVE; AROMATIC HYDROCARBON RECEPTOR; ELLIPTICINE DERIVATIVE; FLAVONE DERIVATIVE; LUCIFERASE; RADIOLIGAND; RUTAECARPINE ALKALOID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; CELL CULTURE; CONTROLLED STUDY; DRUG SYNTHESIS; GENETIC TRANSFECTION; LIVER CYTOSOL; MALE; MOLECULAR MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; REPORTER GENE; STRUCTURE ACTIVITY RELATION;

ANIMALS; DNA; ELLIPTICINES; ENHANCER ELEMENTS (GENETICS); FLAVONOIDS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ARYL HYDROCARBON; STRUCTURE-ACTIVITY RELATIONSHIP; TETRACHLORODIBENZODIOXIN;

EID: 0030582844     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00600-4     Document Type: Article

References (59)

1. 1. Burbach KM, Poland A and Bradfield CA, Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc Nad Acad Sci USA 89: 8185-8189, 1992.
2. 2. Whitlock JP, Jr, Mechanistic aspects of dioxin action. Chem Res Toxicol 6: 754-763, 1993.
3. 3. Huang ZJ, Edery I and Rosbash M, PAS is a dimerization domain common to Drosophila Period and several transcription factors. Nature 364: 259-262, 1993.
4. 4-Reyes H, Reisz-Porszasz S and Hankinson O, Identification of the Ah receptor nuclear translocator (Arnt) as a component of the DNA binding form of the Ah receptor. Science 256: 1193-1195, 1992.
5. 2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
6. 6. Perdew GH, Association of the Ah receptor with 90-kDa heat shock protein. J Biol Chem 263: 13802-13805, 1988.
7. 7. Chen H-S and Perdew G, Subunit composition of the heteromeric cytosolic aryl hydrocarbon receptor complex. J Biol Chem 269: 27554-27558, 1994.
8. 8. Henry EC and Gasiewicz TA, Transformation of the Ah receptor to a DNA-binding form is accompanied by release of hsp90 and increased affinity for TCDD. Biochem J 294: 95-101, 1993.
9. 9. Elferink CJ, Gasiewicz TA and Whitlock JP, Jr, Protein-DNA interactions at a dioxin-responsive enhancer: Evidence that the transformed Ah receptor is heteromeric. J Biol Chem 265: 20708-20712, 1990.
10. 10. Pollenz RS, Sattler CA and Poland A, The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. Mol Pharmacol 45: 428-438, 1994.
11. 11. DeVito MJ and Birnbaum LS, Toxicology of dioxins and related chemicals. In: Dioxins and Health (Ed. Schechter A). pp. 139-155. Plenum Press, New York, 1994.
12. 12. Denison MS, Fisher JM and Whitlock JP, Jr. The DNA recognition site for the dioxin-Ah receptor complex: Nucleotide sequence and functional analysis. J Biol Chem 263: 17221-17224, 1988.
13. 13. Quattrochi LC, Vu T and Tukey RH, The human CYP1A2 gene and induction by 3-methylcholanthrene: A region of DNA that supports Ah-receptor binding and promoter-specific induction. J Biol Chem 269: 6949-6954, 1994.
14. 14. Paulson KE, Darnell JE, Rushmore T and Pickett CB, Analysis of the upstream elements of the xenobiotic compound inducible and positionally regulated glutathione S-transferase Ya gene. Mol Cell Biol 10: 1841-1852, 1990.
15. 15. Takimoto K, Lindahl R, Dunn TJ and Pitot HC, Structure of the 5′ flanking region of class 3 aldehyde dehydrogenase in the rat. Arch Biochem Biophys 312: 539-546, 1994.
16. 16. Favreau LV and Pickett CB, Transcriptional regulation of the rat NAD(P)H:quinone reductase gene: Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. J Biol Chem 266: 4556-4561, 1991.
17. 17. Poellinger L, Gottlicher M and Gustafsson J-A, The dioxin and peroxisome proliferator-activated receptors: nuclear receptors in search of endogenous ligands. Trends Pharmacol Sci 13: 241-245, 1992.
18. 18. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SST, Kimura S, Nebert DW, Rudikoff S, Ward JM and Gonzalez FJ, Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268: 722-726, 1995.
19. 19. Poland A, Glover E and Kende A, Stereospecific high binding affinity of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosols. Evidence that the binding species is a receptor for induction of aryl hydrocarbon hydroxylase. J Biol Chem 251: 4936-4946, 1976.
20. 20. Safe S, Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit Rev Toxicol 21: 51-88, 1990.
21. 21. Pliszczynska JP, Keys B, Safe S and Newman MS, The cytosolic receptor binding affinities and AHH induction potencies of 20 polynuclear aromatic hydrocarbons. Toxicol Lett 34: 67-74, 1986.
22. 22. Rannug U, Sjogren M, Rannug A, Gillner M, Toftgard R, Gustafsson J-A, Rosenkranz H and Klopman G, Use of artificial intelligence in structure-affinity correlations of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) receptor ligands. Carcinogenesis 12: 2007-2015, 1991.
23. 23. Biegel L, Harris M, Davis D, Rosengren R, Safe E and Safe S, 2,2′,4,4′,5,5′-Hexachlorobiphenyl as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57B1/6J mice. Toxicol Appl Pharmacol 97: 561-571, 1989.
24. 24. Luster MI, Hong LH, Osborne R, Blank JA, Clark G, Lilver MT, Boorman GA and Greenlee WF, 1-Amino-3,7-8-trichlorodibenzo-p-dioxin: A specific antagonist for TCDD-induced myelotoxicity. Biochem Biophys Res Commun 139: 747-756, 1986.
25. 125I]methyl-8-iodo-1,3-dichlorodibenzofuran-Ah receptor complexes. Arch Biochem Biophys 284: 193-200, 1991.
26. 26. Blank JA, Tucker AN, Sweatlock J, Gasiewicz TA and Luster MI, α-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression. Mol Pharmacol 32: 168-172, 1987.
27. 27. Santostefano M, Merchant M, Arellano E, Morrison V, Denison MS and Safe S, α-Naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation. Mol Pharmacol 43: 200-206, 1993.
28. 28. Fernandez N, Roy M and Lesca P, Binding characteristics of Ah receptors from rats and mice before and after separation from hepatic cytosols. 7-Hydroxyellipticine as a competitive antagonist of cytochrome P-450 induction. Eur J Biochem 172: 585-592, 1988.
29. 29. Kurl RN, DePetrillo PB and Olnes MJ, Inhibition of Ah (dioxin) receptor transformation by 9-hydroxyellipticine. Involvement of protein kinase C? Biochem Pharmacol 46: 1425-1433, 1993.
30. 30. Mahon JM and Gasiewicz TA, Chelatable metal ions are not required for aryl hydrocarbon receptor transformation to a DNA binding form. Phenanthrolines are possible competitive antagonists of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Biochem Biophys 297: 1-8, 1992.
31. 31. LePecq JB, Dat-Xuong N, Grosse C and Paoletti C, A new antitumoral agent (9-hydroxy ellipticine). Possibility of a rational design of anticancer drugs in the series of DNA intercalating agents. Proc Natl Acad Sci USA 71: 5078-5082, 1974.
32. 32. Multon E, Riou J-F, LaFevre D, Ahomadegbe J-C and Riou G, Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417. Biochem Pharmacol 38: 2077-2086, 1989.
33. 33. Doyle BG, Gogan F, Gowan JE, Keane J and Wheeler TS, Transformation reactions. I. The mechanism of the transformation of o-aroyloxyacetoarones into p-hydroxydiaroylmethanes, and the synthesis of flavones. Sci Proc, Royal Dublin Soc 291-304, 1948.
34. 34. Nowlan NV, Slavin PA and Wheeler TS, The effect of bond structure on the transformation of o-aroyloxyacetoarones into o-hydroxydiaroylmethanes. Baker-Venkataraman Transformation. J Chem Soc 340-344, 1950.
35. 35. Cunningham BDM, Threadgill MD, Groundwater PW, Dale IL and Hickman JA, Synthesis and biological evaluation of a series of flavones designed as inhibitors of protein tyrosine kinases. Anticancer Drug Des 7: 365-384, 1992.
36. 36. Gasiewicz TA and Bauman PA, Heterogeneity of the rat hepatic Ah receptor and evidence for transformation in vitro and in vivo. J Biol Chem 262: 2116-2120, 1987.
37. 37. Waddell WJ, A simple ultraviolet spectrophotometric method for the determination of protein. J Lab Clin Med 48: 311-314, 1956.
38. 38. Gasiewicz TA and Neal RA, The examination and quantitation of tissue cytosolic receptors for 2,3,7,8-tetrachlorodibenzo-p-dioxin using hydroxylapatite. Anal Biochem 124: 1-11, 1982.
39. 39. Gasiewicz TA and Rucci G, Cytosolic receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Evidence for a homologous nature among various mammalian species. Mol Pharmacol 26: 90-98, 1984.
40. 40. Gasiewicz TA and Rucci G, α-Naphthoflavone acts as an antagonist of 2,3,7,8-tetrachlorodibenzo-p-dioxin by forming an inactive complex with the Ah receptor. Mol Pharmacol 40: 607-612, 1991.
41. 41. Gillner M, Bergman J, Cambillau C and Gustaffson J-A, Interactions of rutaecarpine alkaloids with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Carcinogenesis 10:651-654, 1989.
42. 50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108, 1973.
43. 43. Bradfield CA and Poland A, A competitive binding assay for 2,3,7,8-tetrachlorodibenzo-p-dioxin and related ligands of the Ah receptor. Moi Pharmacol 34: 682-688, 1988.
44. 44-Lusska A, Shen E and Whitlock JP, Jr, Protein-DNA interactions at a dioxin-responsive enhancer. Analysis of six bona fide DNA-binding sites for the liganded Ah receptor. J Biol Chem 268: 6575-6580, 1993.
45. 45. Bagchi MK, Tsai SY, Weigel ML, Tsai M-J and O'Malley BW, Regulation of in vitro transcription by progesterone receptor. J Biol Chem 265: 5129-5134, 1990.
46. 46. Carrier F, Owens RA, Nebert DW and Puga A, Dioxin-dependent activation of murine CYP1A1 gene transcription requires protein kinase C-dependent phosphorylation. Mol Cell Biol 12: 1856-1863, 1992.
47. 47. Waller CL and McKinney JD, Three-dimensional quantitative structure-activity relationships of dioxins and dioxin-like compounds: Model validation and Ah receptor characterization. Chem Res Toxicol 8: 847-858, 1995.
48. 48. Lu Y-F, Santostefano M, Cunningham BDM, Threadgill MD and Safe S, Identification of 3′-methoxy-4′-nitroflavone as a pure aryl hydrocarbon (Ah) receptor antagonist and evidence for more than one form of the nuclear Ah receptor in MCF-7 human breast cancer cells. Arch Biochem Biophys 316: 470-477, 1995.
49. 49. Liu H, Santostefano M, Lu Y and Safe S, 6-Substituted 3,4-benzocoumarins: A new structural class of inducers and inhibitors of CYP1A1-dependent activity. Arch Biochem Biophys 306: 223-231, 1993.
50. 50. Gillner M, Bergman J, Cambillau C, Fernstrom B and Gustafsson J-A, Interactions of indoles with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Mol Pharmacol 28: 357-363, 1985.
51. 51. Lesca P, Lecointe P, Pelaprat D, Paoletti C and Mansuy D, Structure-activity relationships in the inhibitory effects of ellipticines on benzo(a)pyrene hydroxylase activity and 3-methylcholanthrene mutagenicity. Biochem Pharmacol 29: 3231-3237, 1980.
52. 52. Poland A and Knutson JC, 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22: 517-554, 1982.
53. 53. Gillner M, Bergman J, Cambillau C, Alexandersson M, Fernstrom A and Gustafsson J-A, Interactions of indolo[3,2-b]carbazoles and related polycyclic aromatic hydrocarbons with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxins in rat liver. Mol Pharmacol 44: 336-345, 1993.
54. 54-Fossé P, René B, Charra M, Paoletti C and Saucier J-M, Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: Structure-activity relationship. Mol Pharmacol 42: 590-595, 1992.
55. 55. Rouesse JG, Le Chevalier T, Caille P, Mondesir J-M, Sancho-Garnier H, May-Levin F, Spielmann M, De Jager R and Amiel J-L, Phase II studies of elliptinium in advanced breast cancer. Cancer Treat Rep 69: 707-709, 1985.
56. 56. Stephenson RP, A modification of receptor theory. Br J Pharmacol 11: 379-393, 1956.
57. 57. Denison MS, Garrison PM, Aarts JMMJG, Tullis K, Shalk JAC, Cox MA and Brauwer A, Species-specific differences in Ah receptor ligand binding and transcriptional activation: Implications for bioassays for the detection of dioxin-like chemicals. Organohalogen Compounds 23: 225-229, 1995.
58. 58. Liu PCC and Matsumura F, Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the "adipose-type" and "brain-type" glucose transporters in mice. Mol Pharmacol 47: 65-73, 1995.
59. 59. Merchant M, Morrison V, Santostefano M and Safe S, Mechanism of action of aryl hydrocarbon receptor antagonists: Inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression. Arch Biochem Biophys 298: 389-394, 1992.